van Loo G, Schotte P, Van Gurp M, Demol H, Hoorelbeke B, Gevaert K, et al
The metabolism of vitamin E
Heerspink HJ, Sattar N, Pavo I, Haupt A, Duffin KL, Yang Z, et al
The researchers found increased risk of several forms of alopecia among those taking GLP-1 medications
a growth hormone-releasing factor analog, is FDA-approved for the treatment of HIV-associated lipodystrophy , with studies showing significant reduction in visceral adipose tissue (VAT) after 26 weeks of useSource: Falutz et al., New England Journal of Medicine, 2010
First, optimal dosing in humans remains undefined, with current practice based primarily on extrapolation from animal studies and anecdotal clinical experience rather than formal dose-finding studies